510(k) Report

510(k) · Cleared

Recalled · Class II · 2022

SpaceOAR System

K202224510(k) SpecialCleared Aug 28, 202021-day reviewClass II21 CFR 892.5725Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Boston Scientific Corporation · OVB Hydrogel Spacer

Cleared on Aug 28, 2020 as substantially equivalent to K181465 (Augmenix, Inc., 2018) after a 21-day review. Its family tree reaches back 2 generations to 2015. 1 later device descends from it. It has been recalled once.

Decided
Aug 28, 2020
Review
21 days
Class
Class II
Product code
OVB
Recalls
1
Predicates
1

Its longest line of descent runs back 2 generations to DEN140030 (2015). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2022: 1 descendant clearedDEN140030 · SpaceOAR System · Augmenix, Inc. · 2015K181465 · SpaceOAR System · Augmenix, Inc. · 2018 · recalled201620182020202220242026
Descendants, by generation 1 generation forward: 1 descendant K181465 · SpaceOAR System · Augmenix, Inc. · 2018 · recalledDEN140030 · SpaceOAR System · Augmenix, Inc. · 20150
  1. Root · 2 generations backDEN140030 SpaceOAR SystemAugmenix, Inc. · 2015
  2. 1 generation backK181465 SpaceOAR SystemAugmenix, Inc. · 2018 · Recalled
  3. This deviceK202224 SpaceOAR SystemBoston Scientific Corporation · 2020
  4. Descendant · cites it directly · 0 of its ownK220641 Barrigel Injectable GelPalette Life Sciences · 2022

Most influential descendants

Showing 1 of 1 · See all
  • K220641Barrigel Injectable GelPalette Life Sciences · 2022 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN140030SpaceOAR SystemAugmenix, Inc.2015—
−1K181465SpaceOAR SystemAugmenix, Inc.20181
0 (this device)K202224SpaceOAR SystemBoston Scientific Corporation2020—
+1K220641Barrigel Injectable GelPalette Life Sciences2022—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202210
FIG. 1 — Lineage of K202224, 2015–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OVB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OVB device

  1. #1 K262151 SpaceOAR Flex™ Systemscore 12.6 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K181465SpaceOAR System
Summary page 4
…Classification Name: Absorbable Perirectal Spacer Classification: Class II Product Code: OVB Identification of Predicate Device: SpaceOAR Hydrogel System, K181465 E. Device Description The SpaceOAR Hydrogel System consists of components for the preparation of a synthetic, absorbab…
Augmenix, Inc.20181

Also cleared against K181465: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K220641Barrigel Injectable GelPalette Life Sciences20220

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Feb 24, 2022Class IIZ-1002-2022Labeling designUsers need to be aware that embolism is a possible adverse event associated with hydrogel misplacements. Updated IFU provides new procedural instructions, warnings and precautions that describe steps to verify correct placement of the…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 5 years and passes through 2 companies; a new generation was cleared every 3.2 years on median.
  • 1 of the 2 ancestors has a recall of any class.
  • Of its descendants, K220641 (Palette Life Sciences, 2022) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K181465.

How does its category compare?

All OVB devices

OVB Hydrogel Spacer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · OVB

2so far in 2026, the most since 2007

2015: 12018: 12019: 12020: 12022: 12023: 12026 (partial year): 2
2007high 2 (2026) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OVB

Too few OVB 510(k)s in any year since 2007 to give a median.

Recalls per year · OVB

2in 2022

2022: 2
2007high 2 (2022) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OVB

339in 2025

2016: 22017: 32018: 112019: 852020: 1262021: 2722022: 3872023: 3272024: 3292025: 339
2007high 387 (2022) · low 0 (2007)2025

MAUDE reports naming product code OVB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20151—00
20160—02
20170—03
20181—011
20191—085
20201—0126
20210—0272
20221—2387
20231—0327
20240—0329
20250—0339
20262—0—

What is it indicated for?

SpaceOAR System is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of SpaceOAR System to reduce the radiation dose delivered to the anterior rectum.

The SpaceOAR System is composed of biodegradable material and maintains space for the entire course of prostate radiotherapy treatment and is completely absorbed by the patient's body over time.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K202224: SpaceOAR System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K202224

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026